NASDAQ:INVO

INVO Bioscience Earning Date

USA |NASDAQ |USD

INVO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 15, 2021 Sep 2021 $-0.20 $-0.17 $-0.57
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 15, 2021 Sep 2021 $330.00K $208.47K $336.07M

Invo Bioscience's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 2021.

INVO Earnings Date & History Chart

INVO Earnings & Revenue Forecast

INVO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.17 $-0.21 $-0.13
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.78 $-0.85 $-0.72
Dec 2022 2 $-0.32 $-0.55 $-0.09

INVO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.17 $-0.09 $-0.09
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.78 $-0.66 $-0.66
Dec 2022 0 / 0 $-0.32 $-0.03 $-0.03

INVO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $880.00K $800.00K $960.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $2.10M $1.94M $2.25M
Dec 2022 2 $9.70M $8.75M $10.65M

INVO Earnings Date & Revenue History

INVO Earnings History

|
Show More
Show More

INVO Revenue History

|
Show More
Show More

Invo Bioscience Next Earnings Date & Report

INVO Next Earnings Date & Report Preview: Sep 2021 (FQ)

INVO's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 2 analysts, the average EPS estimation for Invo Bioscience's next quarterly earnings is $-0.20, with a low EPS estimation of $-0.22, and a high estimation of $-0.18.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.20, the last 2 month trend is $-0.13, and the 3 month trend is $-0.13.

Based on 2 analysts, the average revenue estimation is $330.00K, with a low revenue estimation of $250.00K, and a high estimation of $400.00K.

Invo Bioscience Previous Earnings Dates & Reports

INVO Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Invo Bioscience's previous earnings date was Aug 16, 2021 for its fiscal quarter ended Jun 30, 2021.

INVO's earnings per share (EPS) was $-0.17, beating the consensus analysts forecast of $-0.19 by 10.53%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -32.00%, and higher than the same period a year before (Jun 2020) by -52.78%.

Revenues were $208.47K, worse than the forecast of $410.00K by -49.15%, up by 6.05% from the previous quarter , and down by -15.28% from the same period last year.

The company reported a net income of $-1.82M.

Free cash flow for the quarter was $-1.18M , compared to $-1.85M last quarter and $-1.16M a year before.

INVO ended the quarter with $1.70M in total debt, an increase of 119.63% compared to the previous quarter, and an increase of 56.12% compared to the same quarter a year before.

INVO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Invo Bioscience's previous annual earnings date was Mar 30, 2021 for its fiscal year ended Dec 31, 2020.

INVO's earnings per share (EPS) was $-1.81, missing the consensus analysts forecast of $-0.98 by 84.20% , and lower than the previous year's EPS (Dec 2019) by 167.44%.

Revenues were $1.04M, worse than the forecast of $1.28M by -18.96%, and down by -29.92% from previous year's revenue.

The company reported a net income of $-8.35M.

Invo Bioscience reported a free cash flow of $-4.86M for its fiscal year, compared to $1.26M a year ago.

The company ended the fiscal year with $775.02K in total debt, an increase of 106.14% compared to the previous year.